FindTrial
Sign In

The observation of hemodynamic performance of various bioprosthetic and mechanical prosthetic valves uses for aortic valve replacement.

An observational study of early hemodynamic performance after aortic valve replacement using various bioprosthetic and mechanical prosthetic valves

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053555
Enrollment
200
Registered
2023-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I39- Endocarditis and heart valve disorders in diseases classified elsewhere

Interventions

Intervention1: Aortic Valve Replacement: In case of sever aortic regirgitation or sever aortic stenosis, replacement of the aortic valve by a bioprosthetic or mechanical valve is a treatment. Control

Sponsors

Ravi Ranjan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: It will include all patients undergoing AVR with LVEF >45%

Exclusion criteria

Exclusion criteria: Active Endocarditis LVEF Multiple procedures Aortic Root Enlargement Patient on MHD

Design outcomes

Primary

MeasureTime frame
To study hemodynamic performance of various mechanical and bioprosthetic valves after AVR.Timepoint: Baseline, 3months and 1 year—

Secondary

MeasureTime frame
To study the ICU stay, respiratory , renal and dysfunction in patients undergoing AVRTimepoint: Baseline, 3months, 1year—

Countries

India

Contacts

Public ContactRavi Ranjan

Fortis Escorts Heart Institute, Okhla, Delhi

zile.meharwal@fortishealthcare.com9810333821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026